Asset and Financial Position of the Bayer Group

Asset and Capital Structure

Bayer Group Summary Statements of Financial Position

 

 

Dec. 31, 2017

 

June 30, 2018

 

Sep. 30, 2018

 

Change

 

 

€ million

 

€ million

 

€ million

 

%

Noncurrent assets

 

45,014

 

98,713

 

97,316

 

−1.4

Assets held for sale

 

2,081

 

3,720

 

235

 

−93.7

Other current assets

 

27,992

 

34,097

 

31,903

 

−6.4

Current assets

 

30,073

 

37,817

 

32,138

 

−15.0

Total assets

 

75,087

 

136,530

 

129,454

 

−5.2

Equity

 

36,861

 

47,219

 

50,417

 

+6.8

Noncurrent liabilities

 

24,633

 

62,549

 

58,841

 

−5.9

Liabilities directly related to assets held for sale

 

111

 

669

 

12

 

−98.2

Other current liabilities

 

13,482

 

26,093

 

20,184

 

−22.6

Current liabilities

 

13,593

 

26,762

 

20,196

 

−24.5

Liabilities

 

38,226

 

89,311

 

79,037

 

−11.5

Total equity and liabilities

 

75,087

 

136,530

 

129,454

 

−5.2

  • Between June 30, 2018, and September 30, 2018, total assets decreased by €7 billion to €129.5 billion.
  • Noncurrent assets decreased by €1.4 billion to €97.3 billion. Deferred taxes declined by €1.0 billion to €3.8 billion.
  • Total current assets decreased by €5.7 billion to €32.1 billion. Assets held for sale were reduced by €3.5 billion to €0.2 billion through the derecognition of the assets divested to BASF. There was also a €2.6 billion reduction in trade accounts receivable to €11.7 billion due to cash receipts, in a development that was mainly attributable to the North American business of Crop Science.
  • Equity rose by €3.2 billion compared with June 30, 2018, to €50.4 billion, with income after income taxes accounting for €2.9 billion. The equity ratio increased to 38.9% as of September 30, 2018 (June 30, 2018: 34.6%).
  • Liabilities fell by €10.3 billion as of September 30, 2018, to €79.0 billion. Noncurrent liabilities decreased by €3.7 billion to €58.8 billion. Financial liabilities in particular declined by €2.2 billion. Deferred taxes also decreased by €1.3 billion. Actuarial gains reduced provisions for pensions and other post-employment benefits by €0.4 billion. Current liabilities fell by €6.6 billion to €20.2 billion. The cash received from the divestments to BASF was used to reduce current financial liabilities. Refund liabilities fell by €1.3 billion.
Compare to Last Year